MREO - Mereo BioPharma Group PLC ADR - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MREO is currently covered by 3 analysts with an average price target of $6.51. This is a potential upside of $4.56 (233.85%) from yesterday's end of day stock price of $1.95.

Mereo BioPharma Group PLC ADR's activity chart (see below) currently has 2 price targets and 24 ratings on display. The stock rating distribution of MREO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 7.41% with an average time for these price targets to be met of 113 days.

Highest price target for MREO is $8, Lowest price target is $7, average price target is $7.33.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 09-Apr-2025. First documented stock forecast 10-Oct-2019.

Best performing analysts who are covering MREO - Mereo BioPharma Group PLC ADR:

Kristen Kluska Gil Blum Joseph Schwartz

Currently out of the existing stock ratings of MREO, 21 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$7

$5.05 (258.97%)

$7

4 days ago
(09-Apr-2025)

0/12 (0%)

$5.1 (268.42%)

Buy

$7

$5.05 (258.97%)

$7

26 days ago
(18-Mar-2025)

2/9 (22.22%)

$4.47 (176.68%)

339

Buy

$8

$6.05 (310.26%)

$8

9 months 24 days ago
(20-Jun-2024)

0/2 (0%)

$4.11 (105.66%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MREO (Mereo BioPharma Group PLC ADR) average time for price targets to be met?

On average it took 113 days on average for the stock forecasts to be realized with a an average price target met ratio 7.41

Which analyst has the current highest performing score on MREO (Mereo BioPharma Group PLC ADR) with a proven track record?

KRISTEN KLUSKA

Which analyst has the current lower performing score on MREO (Mereo BioPharma Group PLC ADR) with a proven track record?

JOSEPH SCHWARTZ

Which analyst has the most public recommendations on MREO (Mereo BioPharma Group PLC ADR)?

Kristen Kluska works at CANTOR FITZGERALD and has 13 price targets and 12 ratings on MREO

Which analyst is the currently most bullish on MREO (Mereo BioPharma Group PLC ADR)?

Joseph Schwartz with highest potential upside - $6.05

Which analyst is the currently most reserved on MREO (Mereo BioPharma Group PLC ADR)?

Gil Blum with lowest potential downside - $5.05

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?